Thiamet G
Thiamet G is a potent and selective inhibitor of O-GlcNAcase (OGA), which acts to remove O-GlcNAc from modified proteins, with Ki of 20 nM for human OGA.
Product Specifications
CAS Number
1009816-48-1
UNSPSC
12352005
Hazard Statement
H317
Target
Autophagy; OGA
Type
Reference compound
Related Pathways
Autophagy; Neuronal Signaling
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/Thiamet-G.html
Concentration
10mM
Purity
99.99
Solubility
DMSO : 233.33 mg/mL (ultrasonic) |H2O : ≥ 50 mg/mL
Smiles
O[C@H]1[C@H](O)[C@@]2([H])N=C(NCC)S[C@@]2([H])O[C@@H]1CO
Molecular Formula
C9H16N2O4S
Molecular Weight
248.30
Precautions
H317
References & Citations
[1]Yuzwa SA, et al. Increasing O-GlcNAc slows neurodegeneration and stabilizes tau against aggregation. Nat Chem Biol. 2012 Feb 26;8 (4) :393-9.|[2]Andrés-Bergós J, et al. The increase in O-linked N-acetylglucosamine protein modification stimulates chondrogenic differentiation both in vitro and in vivo. J Biol Chem. 2012 Sep 28;287 (40) :33615-28.|[3]Ding N, et al. Thiamet-G-mediated inhibition of O-GlcNAcase sensitizes human leukemia cells to microtubule-stabilizing agent NSC 125973. Biochem Biophys Res Commun. 2014 Oct 24;453 (3) :392-7.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
23313151 3x 1.0 µg DNA
HIST1H2AB CRISPR All-in-one AAV vector set (with saCas9)(Human)
Sign In for Pricing
View Details 
PA1020-Fluoro594 100 µg/Vial
Anti-CD40L/CD40LG Antibody Picoband® Fluoro594 Conjugated
Sign In for Pricing
View Details